Official Title: “Open-Label, Multi-Centre, Study of Levitra 10 mg Once a Day in Males With Erectile Dysfunction Was Carried Out in Four Centres Namely Lagos, Port Harcourt, Enuge and Maiduguri at Their University Teaching Hospitals”

Study to investigate the efficacy and safety of Vardenafil

Study Type: Interventional

Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Crossover Assignment, Safety/Efficacy Study

Erectile dysfunction (ED) is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. An ideal treatment option should be effective and reliable, have minimal side effects, be simple to use and affordable. The purpose was the evaluation of efficacy and safety of 10 mg oral Vardenafil in Nigerian subjects with Erectile Dysfunction (ED).

Intervention(s) in this Clinical Trial

• Drug: Levitra (Vardenafil, BAY38-9456)
  • 10mg taken 1 hours before sexual intercourse

Arms, Groups and Cohorts in this Clinical Trial

• Experimental: Arm 1

Primary Measures

• International Index of Erectile Function- Erectile Function domain
  • Time Frame: 8 weeks
    Safety Issue?: No

Secondary Measures

• Global Assessment Questionnaire (GAQ)
  • Time Frame: 8 weeks
    Safety Issue?: No
• Safety and tolerability
  • Time Frame: 8 weeks
    Safety Issue?: Yes

Inclusion Criteria:

• Men ≥ 18 years of age
• Erectile Dysfunction

Exclusion Criteria:

• History of myocardial infarction, stroke or life-threatening arrhythmia within prior 6 month
• Nitrate therapy
• Other exclusion criteria apply according to the Summary of Product Characteristics

Gender Eligibility for this Clinical Trial: Male

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Lead Sponsor: Bayer

Overall Clinical Trial Officials and Contacts

Bayer Study Director Study Director Bayer  

Information obtained from ClinicalTrials.gov on August 29, 2008

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00662441

Study ID Number: 100578

ClinicalTrials.gov Identifier: NCT00662441

Health Authority: Nigeria: The National Agency for Food and Drug Administration and Control

Click here to find results for studies related to marketed products

Click here to find results for studies related to marketed products

Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product